BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36095936)

  • 1. Determination and pharmacokinetic study of riociguat by UPLC-MS/MS in human plasma.
    Kocak OF; Albayrak M; Yaman ME; Atila A; Kadioglu Y; Araz O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1210():123454. PubMed ID: 36095936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel, rapid and sensitive UPLC-MS/MS method for the determination of macitentan in patients with pulmonary arterial hypertension.
    Albayrak M; Atıla A; Yılmazel Ucar E; Araz O; Kadıoglu Y
    Biomed Chromatogr; 2019 May; 33(5):e4502. PubMed ID: 30725476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validated UPLC-MS/MS method for the determination of CX3002 in human plasma and its application to a pharmacokinetic study.
    Hu X; Xu Y; Chen J; Shen Y; Yang D; Hu Y; Jiang B; Lou H; Ruan Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1183():122954. PubMed ID: 34628186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an oral pharmacokinetic study.
    Mangla B; Alam O; Rub RA; Iqbal M; Singh A; Patel KS; Kohli K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122260. PubMed ID: 32679526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UPLC-MS/MS determination of voriconazole in human plasma and its application to a pharmacokinetic study.
    Wang Z; Huang CK; Sun W; Xiao C; Wang ZS
    Biomed Chromatogr; 2015 Feb; 29(2):188-93. PubMed ID: 24925071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid LC-MS/MS method for simultaneous determination of berberine and irbesartan in rat plasma: Application to the drug-drug pharmacokinetic interaction study after oral administration in rats.
    Zhou H; Li W; Sun L; Li W; Liu Q
    Biomed Chromatogr; 2021 Sep; 35(9):e5144. PubMed ID: 33880775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative bioanalytical assay for the human epidermal growth factor receptor (HER) inhibitor dacomitinib in rat plasma by UPLC-MS/MS.
    Qiu X; Lin Q; Ning Z; Qian X; Li P; Ye L; Xie S
    J Pharm Biomed Anal; 2019 Mar; 166():66-70. PubMed ID: 30612075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of acetochlor by UPLC-MS
    Lu D; Zheng X; Xue H; You J; Yin L; Shi M
    Anal Biochem; 2024 May; 688():115476. PubMed ID: 38286351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and sensitive method for quantification of ibrutinib in rat plasma by UPLC-ESI-MS/MS: validation and application to pharmacokinetic studies of a novel ibrutinib nanocrystalline.
    Sun S; Cheng D; Kong S; Li X; Li T; Yu Q; Wang L
    Biomed Chromatogr; 2020 Jan; 34(1):e4703. PubMed ID: 31629393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
    Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L
    J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS.
    Li Y; Meng L; Ma Y; Li Y; Xing X; Guo C; Dong Z
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UPLC-MS/MS determination of phentolamine in human plasma and its application to a pharmacokinetic study.
    Kan X; Zheng SL; Zhou CY
    Drug Res (Stuttg); 2014 Nov; 64(11):607-12. PubMed ID: 24452521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of fascaplysin in rat plasma with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS): application to a pharmacokinetic study.
    Hu Z; Zhang M; He M; Fang B; Bao X; Yan X; Liang H; Wang H
    J Pharm Biomed Anal; 2019 Jul; 171():126-131. PubMed ID: 30986762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UPLC-MS/MS Assay for Quantification of Wedelolactone and Demethylwedelolactone in Rat Plasma and the Application to a Preclinical Pharmacokinetic Study.
    Wang BE; Zhang LT; Yang SB; Xu ZL
    Comb Chem High Throughput Screen; 2022 Jun; 25(8):1271-1277. PubMed ID: 35708104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An LC-MS/MS spectrometry method for the simultaneous determination of Rosuvastatin and Irbesartan in rat plasma: Insight into pharmacokinetic and drug-drug interaction studies.
    Elgawish MS; Soltan MK; Sebaiy MM
    J Pharm Biomed Anal; 2019 Sep; 174():226-234. PubMed ID: 31181484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous Determination of Aesculin, Aesculetin, Fraxetin, Fraxin and Polydatin in Beagle Dog Plasma by UPLC-ESI-MS/MS and Its Application in a Pharmacokinetic Study after Oral Administration Extracts of
    Wang Z; Zhu W; Liu H; Wu G; Song M; Yang B; Yang D; Wang Q; Kuang H
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30205426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of rutin in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and application to pharmacokinetic study.
    Chen M; Zhang X; Wang H; Lin B; Wang S; Hu G
    J Chromatogr Sci; 2015 Apr; 53(4):519-25. PubMed ID: 25030991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of UFLC-MS/MS method for determination of bosentan in rat plasma.
    Atila A; Ozturk M; Kadioglu Y; Halici Z; Turkan D; Yayla M; Un H
    J Pharm Biomed Anal; 2014 Aug; 97():33-8. PubMed ID: 24803031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of acacetin in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
    Fan LH; Li X; Chen DY; Zhang N; Wang Y; Shan Y; Hu Y; Xu RA; Jin J; Ge RS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():18-22. PubMed ID: 25703948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic Study of Hypaphorine, a Potential Agent for Treating Osteoclast-based Bone Loss, on Rats Using LC-MS/MS.
    Zhang T; Yan Y; Xue Y; Xiong S; Ran W; Xu Q
    Comb Chem High Throughput Screen; 2022; 25(11):1889-1896. PubMed ID: 34610780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.